
Managing agitated older patients requires distinguishing between behavioral disturbances linked to baseline dementia and acute delirium triggered by medical issues like infections, electrolyte imbalances, or medication side effects. While environmental interventions—such as dimming lights, involving family for reassurance, and removing unnecessary physical restraints—serve as the first line of defense, pharmacological intervention becomes necessary when patients pose a danger to themselves or staff. Standard treatments for younger patients, specifically benzodiazepines and antihistamines like Benadryl, should be avoided in the elderly due to risks of prolonged sedation, respiratory depression, and urinary retention. Instead, preferred medications include olanzapine, risperidone, or quetiapine. Quetiapine is particularly indicated for patients with Parkinson’s disease or Lewy body dementia because it minimizes adverse interactions with their underlying neurological conditions. Prioritizing these targeted medications over traditional sedatives prevents the exacerbation of delirium and improves safety outcomes for geriatric patients in emergency settings.
Sign in to continue reading, translating and more.
Continue